arrow
N

Nathalie Droin

gustave roussy
H指数:60
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Non-canonical caspase-8 activation by cathepsin B drives anti-inflammatory human macrophage polarization

半胱天冬酶-8的非经典激活由组织蛋白酶B驱动抗炎人巨噬细胞极化

2026-10-290
OAAI
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?

严格的细胞减灭术能否改善进展性慢性髓单核细胞白血病的生存率?

Leukemia
IF13.4
2026-03-090
OAAI
Single-cell multiplex approaches deeply map ON-target CRISPR-genotoxicity and reveal its mitigation by palbociclib and long-term engraftment

单细胞多重方法深度绘制靶向CRISPR-基因组毒性图谱,并揭示其可通过帕博西林和长期移植得到缓解。

2026-01-100
OAAI
Patritumab deruxtecan in HR+HER2− advanced breast cancer: a phase 2 trial

帕梯他马单抗德鲁克替康在HRHER2+−晚期乳腺癌中的治疗:一项II期临床试验

2025-09-040
OAAI
INCORPORATING TET2 VARIANT ALLELE FREQUENCY ENHANCES PROGNOSTICATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA: A MULTICENTER STUDY

纳入TET2变异等位基因频率可增强慢性粒单细胞白血病的预后评估:一项多中心研究

2025-09-010
PRE
Monocytes generated by interleukin-6-treated human hematopoietic stem and progenitor cells secrete calprotectin that inhibits erythropoiesis

由白介素-6处理的造血干细胞和祖细胞生成的单核细胞分泌钙卫蛋白,该物质抑制红细胞生成。

2025-01-010
PRE
Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways
2024-11-220
OAAI
Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des Myélodysplasies (GFM) study
LEUKEMIA
IF13.4
2024-09-120
PRE
Unraveling the mechanisms of action and resistance to trastuzumab deruxtecan (T-DXd): Supplementary biomarker analyses from DAISY trial

揭示曲妥珠单抗德鲁替康(T-DXd)的作用机制和耐药机制:DAISY试验的补充生物标志物分析

2024-09-010
PRE
RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
2024-08-270
PRE
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells
2024-07-150
OAAI
Germline and acquired genetic variants and long-term cancer-related fatigue among survivors of early-stage breast cancer (BC)
2024-05-020
PRE
Association of clonal hematopoiesis (CH) with clinical outcomes among survivors of breast cancer (BC)
2024-05-020
PRE
Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation

由于SF3B1突变的骨髓增生异常综合征中R环丢失而导致DNA复制叉速度加快

2024-04-084
OAAI
TCTP regulates genotoxic stress and tumorigenicity via intercellular vesicular signaling
2024-03-281
OA
Clinical and translational results of the academic ARIANES Phase 2 basket study: Longitudinal single-cell analysis of patient tumors identifies biological correlates of response to PARP inhibitors and anti-PD-L1 therapy
2024-03-220
PRE
SRSF2 plays an unexpected role as reader of m5C on mRNA, linking epitranscriptomics to cancer

SRSF2作为mRNA上m5C的阅读器起着意想不到的作用,将epitranscripttomics与癌症联系起来

2023-12-0118
OAAI
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial
2023-07-24130
OAAI
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice
LEUKEMIA
IF13.4
2023-04-263
OA
Enhancer deregulation in TET2- mutant clonal hematopoiesis is associated with increased COVID-19 severity and mortality
2023-04-041
PRE